← Back to patent-cliff list
GEn1E-1124
Tier C — Watch / tradeGEn1E-1124
GEn1E Lifesciences Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：MAPKs
Indications (approved)：Acute respiratory distress syndrome
Regional status
US
Phase II
2023-04-04
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of GEn1E-1124?
Approved indications include: Acute respiratory distress syndrome.
When does the GEn1E-1124 patent expire?
No public expiry year is available for GEn1E-1124 yet; this page updates once verified.
How do I get a quote for GEn1E-1124 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03